Shao Jiong 4
4 · Sorrento Therapeutics, Inc. · Filed Apr 23, 2019
Insider Transaction Report
Form 4
Shao Jiong
Chief Financial Officer
Transactions
- Award
Stock Options
2019-04-19+200,000→ 200,000 totalExercise: $3.78Exp: 2029-04-19→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]1/4th of the original number of shares subject to the option shall vest on April 14, 2020 and 1/48th of the original number of shares subject to the option shall vest following each one month period of service after April 14, 2020, subject to the Reporting Person's continued service to the Issuer through each such vesting date.